The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...
A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...
Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates. | The administration's second stab ...
LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered ...
The American Hospital Association has urged the Health Resources and Services Administration to abandon its consideration of the 340B rebate model pilot program, arguing the approach would impose ...
While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.
In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...
The U.S. District Court for the District of Columbia March 31 vacated a Health Resources and Services Administration policy instituted in 2013 that restricted how certain 340B hospitals could make ...
AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...
The U.S. Court of Appeals for the Ninth Circuit just disrupted that assumption. In Adventist Health System of West v. AbbVie, ...
Senate Bill 5981, signed into law by Gov. Bob Ferguson on March 25, strengthened the federal 340B Drug Pricing Program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results